← Evidence map

ArticleMolecular therapy. Nucleic acids2024

CRISPR-Cas9-directed gene therapy for spinocerebellar ataxia type 1.

Mihai Miclăuș et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39629115